Effect of interleukin-28B on treatment outcome in hepatitis C virus G1/4 patients receiving response-guided therapy with pegylated interferon alpha-2a/ribavirin
Brian L. Pearlman, Carole EhlebenVolume:
55
Year:
2012
Language:
english
Pages:
1
DOI:
10.1002/hep.25552
File:
PDF, 1.05 MB
english, 2012